Physician profile
Andre Nunn
NPI 1447351655
$18,196.30
in general payments reported to CMS, 2019-2025
20 companies · $813 in 2025
The $813 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $344 · 2020: $202 · 2021: $9,039 · 2022: $624 · 2024: $7,174 · 2025: $813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $3,134 · Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $3,133.76 |
| Food and Beverage | $853.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,086.80 | 2021-2024 | |
| Medtronic, INC. | $1,326.04 | 2024-2025 | Endoflip, Ligasure, Progrip |
| Novo Nordisk INC | $869.60 | 2020-2022 | |
| Tela Bio, INC. | $639.71 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Davol INC. | $468.06 | 2019-2025 | Phasix Mesh |
| Ethicon US, LLC | $215.88 | 2021-2025 | Enseal X1, Ethicon, Surgicel Nu-Knit |
| Apollo Endosurgery US INC | $208.75 | 2021-2022 | |
| Baxter Healthcare | $94.66 | 2024 | Perclot |
| Lsi Solutions INC | $51.47 | 2024 | Ti-Knot |
| Lilly USA, LLC | $39.92 | 2021 | |
| Abbvie INC. | $35.36 | 2024-2025 | |
| Kerecis Limited | $30.03 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Bsn Medical INC | $20.91 | 2022 | |
| Solventum Corporation | $19.90 | 2025 | Activ.A.C. |
| Merck Sharp & Dohme LLC | $16.87 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.19 | 2019 | |
| Reprise Biomedical, INC. | $15.55 | 2025 | Miro3d |
| Currax Pharmaceuticals LLC | $14.78 | 2022 | |
| Aveo Pharmaceuticals, INC. | $14.13 | 2024 | |
| Olympus America INC. | $11.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Nunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.